Arca Biopharma

ABIO

1.20

+0.03

+2.1%

After Hours:

1.20

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 1.20
Prev. Close: 1.17
Low/Hi: 1.15 - 1.20
52-Week: 1.05 - 3.00
Volumes
Equity: 49,061
90-Day Avg: 140,539
Volatility
Todays Stock Vol: 33.4
20-Day (HV): 81.6
52-Week (HV): 73.5
Fundamental
Div. Yield: 0.0%
Earnings: 14-Nov (Est.)
P/E Ratio:
Market Cap: 16.9 M
Stock Type: Common
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

ABIO Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Net Income -5,522 -4,338 -4,244 -4,659
Change in Working Capital 313 -259 274 496
Depreciation Amortization Depletion and Accretion 132 152 157 160
Deferred Taxes 0 0 0 0
Other Non-Cash Activities 119 101 -29 267
Total Cash from Operating Activities -4,958 -4,344 -3,842 -3,736
Capital Expenditures -2 0 -4 -6
Other Investing Cash Flow 6,103 3,008 3,152 -2,542
Total Cash from Investing Activities 6,101 3,008 3,148 -2,548
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 2,074 210 0 0
Purchase and Retirement of Debt -170 0 0 0
Other Financing Cash Flow -116 -105 0 0
Total Cash from Financing Activities 1,788 105 0 0
Exchange Rate Effects 0 0 0 0
Net Change in Cash 2,931 -1,231 -694 -6,284
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Net Income -16,444 -11,445 -9,689 -8,965
Change in Working Capital 400 104 -443 1,342
Depreciation Amortization Depletion and Accretion 481 208 79 26
Deferred Taxes 0 0 0 0
Other Non-Cash Activities 576 599 647 283
Total Cash from Operating Activities -14,987 -10,534 -9,406 -5,288
Capital Expenditures -12 -11 -19 -32
Other Investing Cash Flow -16,402 0 0 0
Total Cash from Investing Activities -16,414 -11 -19 -32
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 0 37,000 9,038 21,741
Purchase and Retirement of Debt 0 -193 -179 -174
Other Financing Cash Flow 0 -2,814 -836 -2,411
Total Cash from Financing Activities 0 33,993 8,023 19,156
Exchange Rate Effects 0 0 0 0
Net Change in Cash -31,401 23,448 -1,402 13,836